Assessment the Prevalence of Pulmonary Tuberculosis Patients at Yirga Cheffe Health Center from 2008-2013, Ethiopia
Clinical Medicine Research
Volume 4, Issue 2, March 2015, Pages: 38-42
Received: Feb. 5, 2015; Accepted: Feb. 19, 2015; Published: Mar. 2, 2015
Views 2461      Downloads 230
Author
Fekadu Alemu Atire, Department of Biology, College of Natural and Computational Sciences, Dilla University, Dilla, Ethiopia
Article Tools
Follow on us
Abstract
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is one of the world’s most devastating human pathogens that cause more than 2 million deaths annually. In addition, an estimated 2 billion people are latently infected with M. tuberculosis. Ethiopia is ranked 7th among TB burden shouldering countries in the world. The data collection was carried out typically by secondary data source from already recorded document. The data was obtained from the data clack of pulmonary tuberculosis patients (PTB) individuals at Yirga Cheffe Health Center. From a total of 1190 subjects who are registered to assessed for tuberculosis diseases at the Yirga Cheffe Health Center study sites, 676 (56.81 %) male were diagnosed followed by female 514 (43.19 %) were diseased by Mycobacterium tuberculosis. The PTB disease were highly predominant among male with increase slightly across the year from 2008-2013 and the highest were 58.75 % at 2013. The TB disease were increased among children from 2008-2013 in both sex (male and female). The highest percentage of pulmonary tuberculosis patients were observed at 2012 on male at age >49 with 10.18 % while on female pulmonary tuberculosis patients were observed at 2011 with 7.32 %. To conclude that the prevalence of PTB disease among both sex at study area were high in early. The pulmonary tuberculosis patients were decreased across the 2008-2013.
Keywords
Ethiopia, Mycobacterium tuberculosis, Pulmonary Tuberculosis Patients, TB, Yirga Cheffe Health Center
To cite this article
Fekadu Alemu Atire, Assessment the Prevalence of Pulmonary Tuberculosis Patients at Yirga Cheffe Health Center from 2008-2013, Ethiopia, Clinical Medicine Research. Vol. 4, No. 2, 2015, pp. 38-42. doi: 10.11648/j.cmr.20150402.13
References
[1]
Abate G (2002). Review: Drug resistance tuberculosis in Ethiopia Problem scenarios and recommendation. Ethiop. Med. J. 40:79-86.
[2]
Ameni G, Wudie A (2003). Preliminary study on bovine tuberculosis in Nazareth municipality abattoir of central Ethiopia. Bulletin of Animal Health and Production in Africa 51: 125-132.
[3]
Assam-Assam J - P, Penlap V B, Cho-Ngwa F, Tedom J-C, Ane-Anyangwe I, Titanji, V P (2011). Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infectious Diseases 11:94.
[4]
Ayele W, Neill S, Zinsstag J, Weiss M, Pavlik I (2004). Bovine tuberculosis: an old disease but a new threat to Africa. International Journal of Tuberculosis and Lung Diseases 8: 924-937.
[5]
Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, Wells C, Nunn P, Blanc L, Raviglione M (2006). Epidemiology of antituberculosis drug resistance (the Global Projecton Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368:2142-2154.
[6]
Bruchfeld J, Aderaye G, Berggren Palme I, Bjorvatan B, Gebremichael S, Lindquist L (2002). Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary TB patients with and without HIV infection. J. Clin. Microbiol. 40:1636-43.
[7]
Buddle B M, Skinner M A, Wedlock D N, deLisle G W, Vordermeier H M, Hewinson R G, (2005). Cattle as a model for development of vaccines against human tuberculosis. Tuberculosis 85: 19-24.
[8]
Cassidy J P (2006). The pathogenesis and pathology of bovine tuberculosis with insights from studies of tuberculosis in humans and laboratory animal models. Veterinary Microbiology 112: 151-161.
[9]
Cosivi O, Grange J M, Daborn C J, Raviglione M C, Fujikura T, Cousins D, Robinson R A, Huchzermeyer H F de Kantor I, and Meslin F X (1998). Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerging Infectious Diseases 4(1): 59-70.
[10]
Demissie M, Gebeyehu M, Berhane Y (1997). Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia. Int. J. Tuberc Lung Dis. 1:64-67.
[11]
Dye C, Scheele S, Dolin P, PathaniaV, Raviglione MC (1999). Global burden of Tuberculosis: estimated Incidence, prevalence, and mortality by country. JAMA 282: 677–86.
[12]
Ejigu GS, Woldeamanuel Y, Shah NS, Gebeyehu M, Selassie A, Lemma E (2008). Microscopic observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int. J. Tuberc Lung Dis.12:332-337.
[13]
Fitzgerald D, Haas DW (2005). Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone.
[14]
Godfrey-Faussett P, Sonnenberg P, Shearer SC, Bruce MC, Mee C, Morris L (2000). Tuberculosis control and molecular epidemiology in a South African gold- mining community. Lancet 356:1066-1071.
[15]
Hudelson P, (1996). Gender differentials in tuberculosis: the role of socio- economic and cultural factors. Tubercle and Lung Disease 77: 391-400.
[16]
Miller B, Schieffelbein C (1998). Tuberculosis. Bull World Health Organ .76:141-143.
[17]
Mitike G, Kebede D, Yeneneh H (1997). Prevalence of anti-tuberculosis drug resistance in Harar Tuberculosis Centre, Ethiopia,. East African Medical Journal 74: (3)158–161.
[18]
O’Reilly L M, Daborn C J (1995). The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuberculosis and Lung Disease 76: 1-46.
[19]
OIE (2010). Bovine tuberculosis. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Part 2, Section 2.4. World Organization for Animal Health, pp: 683-698.
[20]
Oloya J, Muma J B, Opuda-Asibo J, Djonne B, Kazwala R, Skjerve E (2007). Risk factors for herd-level bovine seropositivity in transhumant cattle in Uganda. Prev. Vet. Med. 80 (4): 318-329.
[21]
Rigouts L, Maregeya B, Traore H, Collart J P, Fissette K, Portaels F (1996). Use of DNA restriction fragment typing in the differentiation of Mycobacterium tuberculosis complex isolates from animals and humans in Burundi. Tuberculosis and Lung Disease 77: 264-268.
[22]
Romha G, Ameni G, Berhe G, Mamo G (2013). Epidemiology of mycobacterial infections in cattle in two districts of Western Tigray Zone, northern Ethiopia. African Journal of Microbiology Research 7(31): 4031-4038.
[23]
Shitaye J E, Getahun B, Alemayehu T, Skoric M Treml F, Fictum P, Vrbas V, Pavlik I (2006). A prevalence study of bovine tuberculosis by using abattoir meat inspection and tuberculin skin testing data, histopathological and IS6110 PCR examination of tissues with tuberculous lesions in cattle in Ethiopia. Veterinarni Medicina 11: 512-522.
[24]
Sulieman M S, Hamid M E (2002). Identification of Acid Fast Bacteria from Caseous Lesions in Cattle in Sudan. Journal of Veterinary Medicine 49: 415-418.
[25]
Teklul A, Asseged B, Yimer E, Gebeyehu M, Woldesenbet Z (2004). Tuberculous lesions not detected by routine abattoir inspection: The experience of the Hosanna municipal abattoir, Southern Ethiopia. Revue Scientifique Technique 23: 957-964.
[26]
TLCP (2002).Tenth annual review meeting, Tuberculosis and Leprosy control Programme (TLCP) Ethiopia, 18 to 20 September 2002.Addis Ababa.
[27]
Van Rhijn I, Godfroid J, Michel A, Rutten V (2008). Bovine tuberculosis as a model for human tuberculosis: advantages over small animal models. Microbes Infect. 10: 710-715.
[28]
WHO (1998). Global tuberculosis control. WHO/ TB/98. 237. Geneva.
[29]
WHO (2003). Global tuberculosis control: Surveillance, Planning, Financing. WHO report 2003. Geneva, Switzerland, WHO/CDS/TB/2003.316.
[30]
WHO (World Health Organization) (2005). Global tuberculosis control: surveillance, planning, financial. WHO report 2005 Geneva, Switzerland.
[31]
WHO (World Health Organization) (2005). Tuberculosis Control: The Situation in the African Region. The 55th session of the WHO original committee for Africa held in Maputo, Mozambique, August 2005, resolution AFR/RC55/R5 Geneva, Switzerland.
[32]
WHO (World Health Organization) (2009). Global tuberculosis control: epidemiology, strategy, financing. Geneva, Switzerland.
[33]
WHO/IUATLD (2000). Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-tuberculosis Dug Resistance Surveillance. Report 2: Prevalence and Trends. World Health Organization, Geneva, WHO/CDS/TB.
[34]
World Health Organization (2011). G. Global Tuberculosis Control WHO Report.
[35]
Zeru F, Romha G, Ameni G (2013). Gross and Molecular Characterization of Mycobacterium tuberculosis Complex in Mekelle Town Municipal Abattoir, Northern Ethiopia. Global Veterinaria 11 (5): 541-546.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186